Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
La Nouvelle Presse Medicale
|
June 28, 1978
[Predictive studies in psychopharmacology (author's transl)]
P Simon, A Spriet
Therapie
|
January 1, 1995
[Pentoxifylline and intermittent claudication: critical analysis of clinical trials]
O L Charansonney, A Spriet
Therapie
|
July 1, 1996
[Essential elements of quality assurance of clinical trials in hospital environment]
A Spriet, P Chaumet-Riffaud
Therapie
|
January 1, 1991
[Drug flow. Good manufacturing practices, good clinical practices]
T Dupin-Spriet, A Spriet
Therapie
|
May 1, 1993
[Clinical trials in Alzheimer disease. Comments on the project of FDA's guidelines]
A Spriet, T Dupin-Spriet
Journal Des Maladies Vasculaires
|
January 1, 1985
[Evaluation of the effectiveness of medical treatment of intermittent claudication]
A Serradimigni, R Jouve, A Spriet
L'Encephale
|
January 1, 1978
[Use of evaluation scales in psychopharmacology]
A Spriet, J Fermanian, P Simon
L'Encephale
|
January 1, 1983
[What phase IV should be like for an anxiolytic agent]
A Spriet, C Spriet-Pourra, P Simon
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1989
[Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results]
M Slama, A Cohen-Solal, A Spriet
Therapie
|
November 7, 1998
[Assessment of preventable iatrogenic drug therapy: methodology. Round Table No 2 at Giens XIII]
J L Imbs, Y Pletan, A Spriet
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
La Nouvelle Presse Medicale
|
June 28, 1978
[Predictive studies in psychopharmacology (author's transl)]
P Simon, A Spriet
Therapie
|
January 1, 1995
[Pentoxifylline and intermittent claudication: critical analysis of clinical trials]
O L Charansonney, A Spriet
Therapie
|
July 1, 1996
[Essential elements of quality assurance of clinical trials in hospital environment]
A Spriet, P Chaumet-Riffaud
Therapie
|
January 1, 1991
[Drug flow. Good manufacturing practices, good clinical practices]
T Dupin-Spriet, A Spriet
Therapie
|
May 1, 1993
[Clinical trials in Alzheimer disease. Comments on the project of FDA's guidelines]
A Spriet, T Dupin-Spriet
Journal Des Maladies Vasculaires
|
January 1, 1985
[Evaluation of the effectiveness of medical treatment of intermittent claudication]
A Serradimigni, R Jouve, A Spriet
L'Encephale
|
January 1, 1978
[Use of evaluation scales in psychopharmacology]
A Spriet, J Fermanian, P Simon
L'Encephale
|
January 1, 1983
[What phase IV should be like for an anxiolytic agent]
A Spriet, C Spriet-Pourra, P Simon
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1989
[Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results]
M Slama, A Cohen-Solal, A Spriet
Therapie
|
November 7, 1998
[Assessment of preventable iatrogenic drug therapy: methodology. Round Table No 2 at Giens XIII]
J L Imbs, Y Pletan, A Spriet
Page
of 3